CAG
CL icon

Crestwood Advisors Group’s Colgate-Palmolive CL Stock Holding History

Crestwood Advisors Group’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.57M Buy
41,837
+2,317
+6% +$207K 0.06% 172
2025
Q4 		$3.12M Buy
39,520
+5,352
+16% +$420K 0.05% 178
2025
Q3 		$2.73M Sell
34,168
-1,628
-5% -$139K 0.05% 180
2025
Q2 		$3.25M Buy
35,796
+173
+0.5% +$15.8K 0.06% 167
2025
Q1 		$3.34M Buy
35,623
+1,253
+4% +$112K 0.06% 160
2024
Q4 		$3.12M Buy
34,370
+194
+0.6% +$18.5K 0.06% 154
2024
Q3 		$3.55M Buy
34,176
+407
+1% +$41.5K 0.07% 144
2024
Q2 		$3.28M Buy
33,769
+98
+0.3% +$9.04K 0.07% 145
2024
Q1 		$3.03M Sell
33,671
-57
-0.2% -$4.83K 0.07% 143
2023
Q4 		$2.69M Buy
33,728
+1,277
+4% +$96K 0.06% 147
2023
Q3 		$2.31M Buy
32,451
+29,286
+925% +$2.19M 0.06% 147
2023
Q2 		$244K Buy
3,165
+84
+3% +$6.5K 0.01% 229
2023
Q1 		$232K Buy
3,081
+379
+14% +$28.2K 0.01% 240
2022
Q4 		$213K Buy
+2,702
New +$203K 0.01% 247
2022
Q3 		– Sell
-2,776
Closed -$222K – 271
2022
Q2 		$222K Sell
2,776
-75
-3% -$5.87K 0.01% 240
2022
Q1 		$216K Sell
2,851
-995
-26% -$78.8K 0.01% 266
2021
Q4 		$328K Sell
3,846
-3,469
-47% -$271K 0.01% 245
2021
Q3 		$553K Sell
7,315
-247,490
-97% -$19.7M 0.02% 194
2021
Q2 		$20.7M Sell
254,805
-7,275
-3% -$595K 0.6% 57
2021
Q1 		$20.7M Sell
262,080
-1,457
-0.6% -$114K 0.65% 55
2020
Q4 		$22.5M Buy
263,537
+3,481
+1% +$288K 0.74% 53
2020
Q3 		$20.1M Buy
260,056
+3,566
+1% +$272K 0.75% 51
2020
Q2 		$18.8M Buy
256,490
+6,434
+3% +$457K 0.75% 47
2020
Q1 		$16.6M Buy
250,056
+3,582
+1% +$253K 0.82% 45
2019
Q4 		$17M Sell
246,474
-2,071
-0.8% -$141K 0.67% 53
2019
Q3 		$18.3M Buy
248,545
+4,505
+2% +$327K 0.8% 49
2019
Q2 		$17.5M Buy
244,040
+10,163
+4% +$721K 0.79% 49
2019
Q1 		$16M Buy
233,877
+4,029
+2% +$260K 1.15% 39
2018
Q4 		$13.7M Sell
229,848
-1,860
-0.8% -$116K 1.09% 44
2018
Q3 		$15.5M Buy
231,708
+97
+0% +$6.46K 1.09% 43
2018
Q2 		$15.2M Buy
231,611
+4,355
+2% +$285K 1.1% 42
2018
Q1 		$16.3M Buy
227,256
+4,747
+2% +$342K 1.28% 33
2017
Q4 		$16.8M Buy
222,509
+3,322
+2% +$243K 1.34% 31
2017
Q3 		$16M Buy
219,187
+2,712
+1% +$195K 1.37% 30
2017
Q2 		$15.7M Buy
216,475
+2,334
+1% +$173K 1.34% 33
2017
Q1 		$15.2M Buy
214,141
+7,317
+4% +$512K 1.34% 35
2016
Q4 		$13.5M Buy
206,824
+15,322
+8% +$1.05M 1.31% 37
2016
Q3 		$14.2M Buy
191,502
+4,470
+2% +$330K 1.7% 26
2016
Q2 		$13.7M Buy
187,032
+4,851
+3% +$345K 1.69% 28
2016
Q1 		$12.9M Buy
182,181
+9,989
+6% +$665K 1.52% 30
2015
Q4 		$11.5M Buy
172,192
+1,924
+1% +$128K 1.38% 33
2015
Q3 		$10.8M Buy
170,268
+17,078
+11% +$1.12M 1.4% 34
2015
Q2 		$10M Buy
153,190
+3,790
+3% +$257K 1.33% 38
2015
Q1 		$10.4M Buy
149,400
+13,605
+10% +$940K 1.48% 37
2014
Q4 		$9.4M Buy
135,795
+4,289
+3% +$290K 1.41% 39
2014
Q3 		$8.58M Buy
131,506
+5,666
+5% +$374K 1.34% 41
2014
Q2 		$8.58M Sell
125,840
-395
-0.3% -$26.5K 1.37% 39
2014
Q1 		$8.19M Buy
126,235
+16,434
+15% +$1.04M 1.34% 36
2013
Q4 		$7.16M Buy
109,801
+4,696
+4% +$301K 1.14% 41
2013
Q3 		$6.23M Buy
105,105
+3,385
+3% +$201K 1.09% 40
2013
Q2 		$5.83M Buy
+101,720
New +$6.04M 1.08% 40

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Crestwood Advisors Group's CL Position: Q1 2026 in Review

Crestwood Advisors Group increased its Colgate-Palmolive (CL) stake by 5.9% in Q1 2026, buying an estimated $207K and bringing the position to 41,837 shares worth $3.57M. The position accounts for 0.06% of the portfolio, ranked #172.

Crestwood Advisors Group first reported a position in CL in Q2 2013 and has held it in 51 quarters since. The position peaked at $22.5M in Q4 2020. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Crestwood Advisors Group held 41,837 shares of Colgate-Palmolive worth $3.57M as of Q1 2026.
  • Crestwood Advisors Group bought 2,317 Colgate-Palmolive shares in Q1 2026, an estimated $207K.
  • Colgate-Palmolive made up 0.06% of Crestwood Advisors Group's portfolio in Q1 2026, its #172 holding.
  • Crestwood Advisors Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 51 quarters since.
  • Crestwood Advisors Group's Colgate-Palmolive position peaked at $22.5M in Q4 2020.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Crestwood Advisors Group's 13F filing for Q1 2026, filed 5 May 2026.